Understanding clinical decision-making in mesothelioma care: a mixed methods study
BMJ Open Respiratory Research, 2022 Introduction Malignant pleural mesothelioma is a rare, incurable cancer arising from previous asbestos exposure; patients have a poor prognosis, with a median survival rate of 8–14 months. Variation in mesothelioma clinical decision-making remains common
Najib Rahman +9 more
doaj +1 more source
Mitochondrial ROS Induce Partial Dedifferentiation of Human Mesothelioma via Upregulation of NANOG
Antioxidants, 2020 The expression of pluripotency factors is a key regulator of tumor differentiation status and cancer stem cells. The purpose of this study was to examine the expression of pluripotency factors and differentiation status of human mesothelioma and the role
Filip Sedlic +8 more
doaj +1 more source
Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033. [PDF]
PLoS ONE, 2017 Malignant mesothelioma is a malignant tumor on the pleura or the peritoneum caused mostly by asbestos. Although asbestos is not currently used in South Korea, the incidence of mesothelioma is increasing due to its long latent period. This study predicted
Kyeong Min Kwak +3 more
doaj +1 more source
The role of CD24 as a potential biomarker for malignant pleural mesothelioma
Egyptian Journal of Chest Disease and Tuberculosis, 2023 Objectives Pleural mesothelioma is a rapidly progressing pleural neoplasm caused by asbestos exposure of a long latency around 30-40 years. Patients with mesothelioma are usually diagnosed at a late stage with poor outcomes in terms of morbidity and ...
Mohamed Shaaban Mousa +4 more
doaj +1 more source
Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. [PDF]
, 2015 BACKGROUND: We have conducted a population-based study of pleural mesothelioma patients with occupational histories and measured asbestos lung burdens in occupationally exposed workers and in the general population.
Burdett, G +9 more
core +2 more sources
Meet the researchers: an alternative method of engaging patients with research in mesothelioma
Research Involvement and Engagement, 2018 Plain English summary There are new ways to engage people with science and research but many patient support groups and charitable organisations still hold traditional meetings to provide updates on their activities and to report new developments in ...
Kate Hill, Mags Portman, Zsuzsanna Tabi
doaj +1 more source
BMJ Open, 2021 Objectives The study aim was to explore experiences of patients with pleural mesothelioma of follow-up care in three National Health Service (NHS) Trusts to develop recommendations for practice.Design The study design was qualitative and comprised three ...
Najib Rahman +6 more
doaj +1 more source
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting [PDF]
, 2019 The management of patients with mesothelioma and thymic malignancy requires continuous multidisciplinary expertise at any step of the disease. A dramatic improvement in our knowledge has occurred in the last few years, through the development of ...
Girard, N +4 more
core +1 more source
Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries
Annals of Global Health, 2023 Background: The causal association between mesothelioma and asbestos exposure is conclusive, and many studies have proved that the trend in asbestos use is a strong predictor of the pattern in mesothelioma cases with an adequate latency time (generally ...
Claudio Gariazzo +2 more
doaj +1 more source
New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. [PDF]
, 2015 Malignant pleural mesothelioma (MPM) is a rare tumor that is challenging to control. Despite some benefit from using the multimodality-approach (surgery, combination chemotherapy and radiation), survival remains poor. However, current research produced a
Cameron, Robert B +2 more
core +2 more sources